DCPrime logo

DCPrime

DCPrime is a biotechnology company developing cancer immunotherapies.

5

Funding Rounds

$26.0m

Money raised

Overview

DCPrime is a biotechnology company developing cancer immunotherapies.

Funding

Funding series

Funding Series Analysis

The company DCPrime has raised a total of $25.98m in funding over 5 rounds.

Key Insights:

  • DCPrime Venture round, March 2018: $18.6m
  • DCPrime Grant (money), January 2016: $6.06m
  • DCPrime Private equity, July 2015: $1.32m
DCPrime logo
DCPrime Venture round, March 2018 $18.6m
DCPrime logo
DCPrime Grant (money), January 2016 $6.06m
DCPrime logo
DCPrime Private equity, July 2015 $1.32m